Keyphrases
Phase I Clinical Trial
100%
High-grade Glioma
100%
Tyrosine
100%
Positron Emission Tomography
100%
Prognostic Value
100%
MRI Volume
40%
Multivariate Analysis
40%
Overall Survival
40%
Tmax
40%
Metabolic
20%
Life Expectancy
20%
Early Change
20%
Potential Biomarkers
20%
Tumor Volume
20%
Prognostic Information
20%
Radiotherapy
20%
Metabolically Active
20%
Multivariate Cox Regression Analysis
20%
Treatment Outcome
20%
Median Overall Survival
20%
Medicine and Dentistry
Neoplasm
100%
positron emission tomographic scan
100%
Clinical Trial
100%
Ganglioglioma
100%
Fluorine-18
100%
Magnetic Resonance Imaging
60%
Overall Survival
60%
Multivariate Analysis
40%
Radiation Therapy
20%
Biological Marker
20%
Proportional Hazards Model
20%
Life Expectancy
20%